Holen Sie sich die Stockscreener-App
222.10
0.05%
0.10
Handel nachbörslich:
222.10
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RMD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Resmed Inc Aktie (RMD) Neueste Nachrichten
ResMed Inc. (NYSE:RMD) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
ResMed stock trades at USD 221.89 after RBC target hike - AD HOC NEWS
ResMed stock heads into the open after September 24 data - AD HOC NEWS
Will ResMed (ASX:RMD) Keep Taking Share in Sleep Apnoea? - Kalkine Media
ResMed Inc. (RMD) Stock forecasts - Yahoo Finance UK
ResMed CEO Farrell: Every Hour of CPAP Use Cuts Healthcare Costs 7% - finance.biggo.com
What Is ResMed Signalling With Its Share Repurchase (ASX:RMD)? - Kalkine Media
ResMed Inc. (RMD) Stock Forecasts - Yahoo Finance
ResMed stock reports 10 percent fiscal revenue growth - AD HOC NEWS
ResMed Inc. $RMD Shares Purchased by State Street Corp - MarketBeat
ResMed Inc. $RMD Shares Sold by Baird Financial Group Inc. - MarketBeat
ResMed stock slips 0.73 percent ahead of the open - AD HOC NEWS
ResMed stock targets 12 to 14 percent EPS growth - AD HOC NEWS
ResMed stock heads into the open after a 0.2 percent gain - AD HOC NEWS
How Is ResMed Reshaping What It Owns (ASX:RMD)? - Kalkine Media
ResMed Targets 12%-14% EPS Growth as GLP-1 Patients Lift Sleep Therapy Demand - MarketBeat
ResMed stock holds gains as analysts highlight sleep apnea growth - AD HOC NEWS
Weekly Recap: FY26 revenue & EPS growth and RBC upgrade, $1.5B buyback - TradingView
ResMed Inc. (RMD) Stock Analysis: A Healthcare Titan With A 10% Potential Upside - DirectorsTalk Interviews
ResMed Stock And Senior Healthcare Shares Linked To Medicare Spending Trends - simplywall.st
ResMed Inc. stock edges lower as analysts lift targets after recent results - AD HOC NEWS
ResMed stock gains on RBC upgrade and new institutional buying - AD HOC NEWS
ResMed Inc. stock gains on analyst upgrade and new investor interest - AD HOC NEWS
ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures - Yahoo Finance
Nykredit A S Makes New Investment in ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock falls Friday, underperforms market - MarketWatch
Bank of America Corp DE Buys New Stake in ResMed Inc. $RMD - MarketBeat
ResMed Shares Jump Following RBC Capital Upgrade to Outperform - TIKR.com
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like. - Barron's
ResMed stock jumps 3% on RBC Capital upgrade to Outperform - Investing.com
This Analyst Just Upgraded ResMed Stock. Here's Why. - Barchart.com
Why ResMed (RMD) Stock Is Up Today - Moomoo
Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)? - Yahoo Finance
Resmed Inc Stock (RMD) Moved Up by 3.05% on Sep 15: A Full Analysis - TradingKey
ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says - marketscreener.com
ResMed Price Target Raised to $262.00/Share From $244.00 by RBC Capital - Moomoo
Is This the Right Time to Retain Resmed Stock in Your Portfolio? - Yahoo Finance
ResMed upgraded at RBC Capital Markets on Q4 positives - Seeking Alpha
RBC Capital Upgrades ResMed(RMD.US) to Buy Rating, Raises Target Price to $262 - Moomoo
Resmed Inc. : RBC Raises to Outperform From S - Moomoo
ResMed Stock: Is RMD Underperforming the Healthcare Sector? - finance.yahoo.com
ResMed Inc. (RMD) Stock Analysis: Exploring 12.90% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
ResMed Stock Slides 9.2% Over 9 Straight Down Days - Trefis
National Pension Service Has $54.85 Million Stock Position in ResMed Inc. $RMD - MarketBeat
WINTON GROUP Ltd Makes New Investment in ResMed Inc. $RMD - MarketBeat
Why Is ResMed (NYSE:RMD) Suddenly Drawing Attention? - Kalkine Media
ResMed Stock Is Up 13% in Three Months, The Buyback Is Doing the Heavy Lifting. Here’s What It Could Be Worth Before 2027. - TIKR.com
ResMed Inc. stock extends eight-day slide as market value drops - ad-hoc-news.de
ResMed Stock Slides 8.6% Over 8 Straight Down Days - Trefis
ResMed stock heads into the open after a 0.2% dip - ad-hoc-news.de
Is ResMed (ASX:RMD) the Steadier Name in Healthcare? - Kalkine Media
ResMed Inc. stock dips as CEO share sale draws investor attention - ad-hoc-news.de
ResMed CEO Michael J. Farrell Executes Stock Options and Sells Shares Under 10b5-1 Plan - Kalkine Media
ResMed CEO Michael Farrell sells $1.11 million of company shares - investing.com
Citi Maintains ResMed(RMD.US) With Hold Rating, Raises Target Price to $240 - moomoo.com
ResMed: A Significant Upside Despite The Perceived Risk (NYSE:RMD) - Seeking Alpha
ResMed CEO Michael Farrell sells $1.11 million of company shares By Investing.com - Investing.com India
ResMed (NYSE:RMD) CEO Michael Farrell Sells 4,991 Shares - MarketBeat
Are Resmed CDI (ASX:RMD) shares good value in 2026? - Rask Media
Citigroup Adjusts Price Target on ResMed to $240 From $235, Keeps Neutral Rating - marketscreener.com
Amundi Trims Holdings in ResMed Inc. $RMD - MarketBeat
ResMed stock heads into the open after a 3.3 percent slide - ad-hoc-news.de
Will ResMed Sleep Research Sharpen Its Case (ASX:RMD)? - Kalkine Media
ResMed Inc. stock falls after valuation warning but fundamentals stay solid - ad-hoc-news.de
ResMed Inc. $RMD Shares Purchased by California State Teachers Retirement System - MarketBeat
ResMed (ASX:RMD) Shares Retreat While FY26 Growth Remains in Focus - Kalkine
Resmed Inc Draws Eyes to Healthcare Pathway (ASX:RMD) - Kalkine Media
Is ResMed Inc (RMD) a Bargain After 3.2% Drop? GF Value Says Und - GuruFocus
1.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):